Lucas TROUDE

Dr. Lucas TROUDE

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2019 in World Neurosurgery
Verified
Journal Article
Closed access
LTLucas TROUDE
Lucas TROUDE
MBMohamed Boucekine
Mohamed Boucekine
MMMarion Montava
Marion Montava
JLJean-Pierre Lavieille
Jean-Pierre Lavieille
JRJean-Marie Régis
Jean-Marie Régis
PRPierre-Hugues Roche
Pierre-Hugues Roche

3 February 2023 in Neurosurgery
Verified
Journal Article
Open access
ABAnne Balossier
Anne Balossier
CTConstantin Tuleasca
Constantin Tuleasca
CDChristine Delsanti
Christine Delsanti
LTLucas TROUDE
Lucas TROUDE
JTJean-Marc Thomassin
Jean-Marc Thomassin
JRJean Régis
Jean Régis
BACKGROUND: Stereotactic radiosurgery (SRS) is one of the main treatment options in the management of small to medium size vestibular schwannomas (VSs), because of high tumor control rate and low cranial nerves morbidity. Series reporting long-term hearing outcome (>3 years) are scarce. OBJECTIVE: To perform a systematic review of the literature and meta-analysis, with the aim of focusing on long-term hearing preservation after SRS. METHODS: Using Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, we reviewed articles published between January 1990 and October 2020 and referenced in PubMed or Embase. Inclusion criteria were peer-reviewed clinical study or case series of VSs treated with SRS (single dose), reporting hearing outcome after SRS with a median or mean audiometric follow-up of at least 5 years. Hearing preservation, cranial nerves outcomes, and tumor control were evaluated. RESULTS: Twenty-three studies were included. Hearing preservation was found in 59.4% of cases (median follow-up 6.7 years, 1409 patients). Main favorable prognostic factors were young age, good hearing status, early treatment after diagnosis, small tumor volume, low marginal irradiation dose, and maximal dose to the cochlea. Tumor control was achieved in 96.1%. Facial nerve deficit and trigeminal neuropathy were found in 1.3% and 3.2% of patients, respectively, both significantly higher in Linear Accelerator series than Gamma Knife series (P < .05). CONCLUSION: Long-term hearing preservation remains one of the main issues after SRS, with a major impact on health-related quality of life. Our meta-analysis suggests that hearing preservation can be achieved in almost 60% of patients after a median follow-up of 6.7 years, irrespective of the technique.

1 October 2018 in World Neurosurgery
Verified
Journal Article
Closed access
LTLucas TROUDE
Lucas TROUDE
MBMohamed Boucekine
Mohamed Boucekine
MMMarion Montava
Marion Montava
JLJean-Pierre Lavieille
Jean-Pierre Lavieille
JRJean-Marie Régis
Jean-Marie Régis
PRPierre-Hugues Roche
Pierre-Hugues Roche

1 April 2019 in Neurochirurgie
Verified
Journal Article
Closed access
FBFlorian Bernard
Florian Bernard
LTLucas TROUDE
Lucas TROUDE
SIS. Isnard
S. Isnard
JLJ.-M. Lemée
J.-M. Lemée
LTL.M. Terrier
L.M. Terrier
PRP.-H. Roche
P.-H. Roche


16 July 2021 in Neurosurgical Review
Verified
Journal Article
Closed access
PDF file
LTLucas TROUDE
Lucas TROUDE
MBMohamed Boucekine
Mohamed Boucekine
ABAnne Balossier
Anne Balossier
GBGuillaume Baucher
Guillaume Baucher
JLJean-Pierre Lavieille
Jean-Pierre Lavieille
PRPierre-Hugues Roche
Pierre-Hugues Roche